Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis

by Nuttapong Ngamphaiboon, Suthinee Ithimakin, Teerada Siripoon, Nattaya Sintawichai, Virote Sriuranpong
Published 2022

Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma

by Apiwat Mutirangura, Pakpoom Supiyaphun, Saengsoon Trirekapan, Virote Sriuranpong, Anavaj Sakuntabhai, Saowanee Yenrudi, Narin Voravud
Published 2018

Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected p...

by Masahiro Fukuoka, Yi Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan Swan Leong, Virote Sriuranpong, Tsu Yi Chao, Kazuhiko Nakagawa, Da Tong Chu, Nagahiro Saijo
Published 2018

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer

by Piyada Sitthideatphaiboon, Chinachote Teerapakpinyo, Krittiya Korphaisarn, Nophol Leelayuwatanakul, Nopporn Pornpatrananrak, Naravat Poungvarin, Poonchavist Chantranuwat, Shanop Shuangshoti, Chatchawit Aporntewan, Wariya Chintanapakdee, Virote Sriuranpong, Chanida Vinayanuwattikun
Published 2022

Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy...

by Tony S K Mok, Te Chun Hsia, Chun Ming Tsai, Kenneth Tsang, Gee Chen Chang, John Wen Cheng Chang, Sirisinha Thitiya, Virote Sriuranpong, Sumitra Thongprasert, Daniel Tt Chua, Nicola Moore, Christian Manegold
Published 2018

Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-...

by Tony Mok, Guia Ladrera, Vichien Srimuninnimit, Virote Sriuranpong, Chong Jen Yu, Sumitra Thongprasert, Jennifer Sandoval-Tan, Jin Soo Lee, Fatima Fuerte, David S. Shames, Barbara Klughammer, Matt Truman, Pablo Perez-Moreno, Yi Long Wu
Published 2018

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

by Byoung Chul Cho, Busayamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Virote Sriuranpong, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, Jong Seok Lee, Helen Mann, Matilde Saggese, Thanyanan Reungwetwattana, Suresh S. Ramalingam, Yuichiro Ohe
Published 2018

Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and...

by Tony Mok, Yi Long Wu, Jin Soo Lee, Chong Jen Yu, Virote Sriuranpong, Jennifer Sandoval-Tan, Guia Ladrera, Sumitra Thongprasert, Vichien Srimuninnimit, Meilin Liao, Yunzhong Zhu, Caicun Zhou, Fatima Fuerte, Benjamin Margono, Wei Wen, Julie Tsai, Matt Truman, Barbara Klughammer, David S. Shames, Lin Wu
Published 2018

Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and...

by Tony Mok, Yi Long Wu, Jin Soo Lee, Chong Jen Yu, Virote Sriuranpong, Jennifer Sandoval-Tan, Guia Ladrera, Sumitra Thongprasert, Vichien Srimuninnimit, Meilin Liao, Yunzhong Zhu, Caicun Zhou, Fatima Fuerte, Benjamin Margono, Wei Wen, Julie Tsai, Matt Truman, Barbara Klughammer, David S. Shames, Lin Wu
Published 2018

To search for new candidate tumor supressor genes in nasopharyngeal carcinoma (NPC)

by Pattamawadee Yanatatsaneejit
Published 2012